New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study reveals mechanism linking heart disease to cancer development

Study reveals mechanism linking heart disease to cancer development

byTel-Aviv UniversityCredit: CC0 Public DomainResearchers at Tel Aviv University (TAU) and the Leviev Cardiothoracic and Vascular Center at the Sheba Medical Center have found a mechanism respon
Oncology April 28,2024
Study reveals mechanism linking heart disease to cancer development

Study reveals mechanism linking heart disease to cancer development

byTel-Aviv UniversityCredit: CC0 Public DomainResearchers at Tel Aviv University (TAU) and the Leviev Cardiothoracic and Vascular Center at the Sheba Medical Center have found a mechanism respon
Oncology April 28,2024
PET/MRI found to accurately classify prostate cancer patients, offer potential to avoid unnecessary biopsies

PET/MRI found to accurately classify prostate cancer patients, offer potential to avoid unnecessary biopsies

bySociety of Nuclear MedicineCredit:Journal of Nuclear Medicine(2024). DOI: 10.2967/jnumed.123.266742PET/MRI can improve diagnostic accuracy for prostate cancer patients and help avo
Oncology April 28,2024
PET/MRI found to accurately classify prostate cancer patients, offer potential to avoid unnecessary biopsies

PET/MRI found to accurately classify prostate cancer patients, offer potential to avoid unnecessary biopsies

bySociety of Nuclear MedicineCredit:Journal of Nuclear Medicine(2024). DOI: 10.2967/jnumed.123.266742PET/MRI can improve diagnostic accuracy for prostate cancer patients and help avo
Oncology April 28,2024
Mini-colons advance colorectal cancer research

Mini-colons advance colorectal cancer research

byEcole Polytechnique Federale de LausanneCredit: L. Francisco Lorenzo-Martín (EPFL)In a breakthrough for cancer research, scientists at EPFL have created lab-grown mini-colons that can accurate
Oncology April 28,2024
Mini-colons advance colorectal cancer research

Mini-colons advance colorectal cancer research

byEcole Polytechnique Federale de LausanneCredit: L. Francisco Lorenzo-Martín (EPFL)In a breakthrough for cancer research, scientists at EPFL have created lab-grown mini-colons that can accurate
Oncology April 28,2024
Potential therapeutic target for small cell lung cancer discovered

Potential therapeutic target for small cell lung cancer discovered

by Melissa Rohman,Northwestern UniversityGraphic model showing how POU2AF2 establishes the poised enhancer via SWI/SNF activity-dependent recruitment of the Polycomb complex in SCLC-P subtype ce
Oncology April 28,2024
Potential therapeutic target for small cell lung cancer discovered

Potential therapeutic target for small cell lung cancer discovered

by Melissa Rohman,Northwestern UniversityGraphic model showing how POU2AF2 establishes the poised enhancer via SWI/SNF activity-dependent recruitment of the Polycomb complex in SCLC-P subtype ce
Oncology April 28,2024
Researchers identify protein that controls CAR T cell longevity

Researchers identify protein that controls CAR T cell longevity

byChildren's Hospital of PhiladelphiaLike a lightbulb, CAR T cells designed to kill cancer often burn out due to exhaustion and poor persistence. Doan et al. discovered that a transcription
Oncology April 28,2024
Researchers identify protein that controls CAR T cell longevity

Researchers identify protein that controls CAR T cell longevity

byChildren's Hospital of PhiladelphiaLike a lightbulb, CAR T cells designed to kill cancer often burn out due to exhaustion and poor persistence. Doan et al. discovered that a transcription
Oncology April 28,2024
A sustainable diagnosis tool for multiple cancers

A sustainable diagnosis tool for multiple cancers

byNature Publishing GroupValidation via cancers diagnosis. Credit:Nature Sustainability(2024). DOI: 10.1038/s41893-024-01323-9An accurate, affordable, environmentally and user-friend
Oncology April 28,2024
A sustainable diagnosis tool for multiple cancers

A sustainable diagnosis tool for multiple cancers

byNature Publishing GroupValidation via cancers diagnosis. Credit:Nature Sustainability(2024). DOI: 10.1038/s41893-024-01323-9An accurate, affordable, environmentally and user-friend
Oncology April 28,2024
Study reveals insights into DDX41 protein's role in blood cancer pathogenesis

Study reveals insights into DDX41 protein's role in blood cancer pathogenesis

by JooHyeon Heo,Ulsan National Institute of Science and TechnologyA schematic image showing the impact of DDX41 mutations on MDS patients. Credit: Won Chan Hwang et al/Ulsan National Institute o
Oncology April 28,2024
Study reveals insights into DDX41 protein's role in blood cancer pathogenesis

Study reveals insights into DDX41 protein's role in blood cancer pathogenesis

by JooHyeon Heo,Ulsan National Institute of Science and TechnologyA schematic image showing the impact of DDX41 mutations on MDS patients. Credit: Won Chan Hwang et al/Ulsan National Institute o
Oncology April 28,2024
Preventive mastectomy less common for black women with breast cancer

Preventive mastectomy less common for black women with breast cancer

by Dennis ThompsonBlack women with cancer in one breast are less likely than white women to have the healthy breast removed as well, a new study has found.Women with cancer affecting one breast often
Oncology April 28,2024
Preventive mastectomy less common for black women with breast cancer

Preventive mastectomy less common for black women with breast cancer

by Dennis ThompsonBlack women with cancer in one breast are less likely than white women to have the healthy breast removed as well, a new study has found.Women with cancer affecting one breast often
Oncology April 28,2024
Some proteogenomic signatures linked to prostate cancer progression in patients with African and European ancestries

Some proteogenomic signatures linked to prostate cancer progression in patients with African and European ancestries

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainCertain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated wit
Oncology April 28,2024
Some proteogenomic signatures linked to prostate cancer progression in patients with African and European ancestries

Some proteogenomic signatures linked to prostate cancer progression in patients with African and European ancestries

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainCertain proteogenomic signatures in the prostate cancers of men of African and European ancestries were associated wit
Oncology April 28,2024
Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies

Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies

byUniversity of SouthamptonCredit: Unsplash/CC0 Public DomainResearchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatmen
Oncology April 28,2024
Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies

Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies

byUniversity of SouthamptonCredit: Unsplash/CC0 Public DomainResearchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatmen
Oncology April 28,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com